MS Speaks
Multiple Sclerosis => TREATMENTS => OCREVUS (ocrelizumab) => Topic started by: agate on October 05, 2019, 07:51:03 am
-
From Multiple Sclerosis News Today (October 4, 2019), a summary of the debate at the recent ECTRIMS conference on whether rituximab (Rituxan) is a reasonable option for MS patients--comparing it with Ocrevus:
https://multiplesclerosisnewstoday.com/news-posts/2019/10/04/ectrims2019-is-rituximab-a-reasonable-option-for-ms-patients/